Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
AstraZeneca PLC | Stockholm | Healthcare | Pharmaceuticals | SEK 2.29T | 32.6x | 1.83 | SEK 1,480 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17.7% Upside | Upgrade to Pro+ | |
Swedish Orphan Biovitrum | Stockholm | Healthcare | Pharmaceuticals | SEK 100.15B | 25.7x | 0.49 | SEK 291.80 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 31.1% Upside | Upgrade to Pro+ | |
Camurus AB | Stockholm | Healthcare | Pharmaceuticals | SEK 34.04B | 79x | -21.17 | SEK 582.50 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 29.7% Upside | Upgrade to Pro+ | |
Vimian Group AB | Stockholm | Healthcare | Pharmaceuticals | SEK 21.27B | 100.6x | 1.24 | SEK 41.40 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24% Upside | Upgrade to Pro+ | |
Bonesupport | Stockholm | Healthcare | Pharmaceuticals | SEK 19.64B | 146.6x | -3.53 | SEK 299.60 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BioGaia B | Stockholm | Healthcare | Pharmaceuticals | SEK 10.96B | 31.2x | -8.47 | SEK 108 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 47.7% Upside | Upgrade to Pro+ | |
Swedencare | Stockholm | Healthcare | Pharmaceuticals | SEK 6.17B | 62.3x | 0.9 | SEK 38.80 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 45.1% Upside | Upgrade to Pro+ | |
Flerie AB | Stockholm | Healthcare | Pharmaceuticals | SEK 3.50B | -13.8x | -0.22 | SEK 44.80 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 25% Upside | Upgrade to Pro+ | |
Enzymatica publ AB | Stockholm | Healthcare | Pharmaceuticals | SEK 1B | -14.9x | -2.49 | SEK 4.12 | -4.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -34.8% Downside | Upgrade to Pro+ | |
Magle Chemoswed | Stockholm | Healthcare | Pharmaceuticals | SEK 636M | 56.5x | 0.36 | SEK 30 | -3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cinclus Pharma Holding AB | Stockholm | Healthcare | Pharmaceuticals | SEK 555.01M | -3.4x | -0.08 | SEK 11.70 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Dicot | Stockholm | Healthcare | Pharmaceuticals | SEK 546.09M | -5.3x | -0.23 | SEK 0.31 | 2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Orexo AB | Stockholm | Healthcare | Pharmaceuticals | SEK 496.88M | -2.4x | 0.04 | SEK 14.40 | -6.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 40.4% Upside | Upgrade to Pro+ | |
Infant Bacterial Therapeutics | Stockholm | Healthcare | Pharmaceuticals | SEK 493.05M | -3.6x | 1.53 | SEK 37.30 | 1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
IRLAB Therapeutics | Stockholm | Healthcare | Pharmaceuticals | SEK 453.33M | -5.4x | -0.08 | SEK 8.44 | 20.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Moberg Pharma | Stockholm | Healthcare | Pharmaceuticals | SEK 370.74M | -1.2x | 0 | SEK 7.92 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 39.8% Upside | Upgrade to Pro+ | |
Isofol Medical | Stockholm | Healthcare | Pharmaceuticals | SEK 323.84M | -7.7x | 0.38 | SEK 1.93 | -3.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Lipum | Stockholm | Healthcare | Pharmaceuticals | SEK 320.31M | -4.6x | -0.22 | SEK 14.90 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Corline Biomedical AB | Stockholm | Healthcare | Pharmaceuticals | SEK 241.48M | -9.3x | 0.01 | SEK 9.86 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Lipidor | Stockholm | Healthcare | Pharmaceuticals | SEK 231.01M | -7.8x | -0.18 | SEK 0.29 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cessatech AS | Spotlight | Healthcare | Pharmaceuticals | SEK 222.35M | -11.2x | -0.2 | SEK 12.66 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vivesto AB | Stockholm | Healthcare | Pharmaceuticals | SEK 128.05M | -3.2x | -0.05 | SEK 0.24 | 1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Enorama Pharma | Stockholm | Healthcare | Pharmaceuticals | SEK 120.95M | -2.4x | -0.08 | SEK 2.23 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pila Pharma AB | Stockholm | Healthcare | Pharmaceuticals | SEK 85.18M | -7.7x | -1.42 | SEK 3.18 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Elicera Therapeutics AB | Stockholm | Healthcare | Pharmaceuticals | SEK 78.96M | -5.4x | -0.14 | SEK 2.28 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Oncozenge AB | Stockholm | Healthcare | Pharmaceuticals | SEK 70.63M | -8.5x | -0.17 | SEK 6.17 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ExpreS2ion Biotech | Stockholm | Healthcare | Pharmaceuticals | SEK 56.36M | -1x | -0.02 | SEK 21.60 | -3.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Odi Pharma | Spotlight | Healthcare | Pharmaceuticals | SEK 42.97M | -9.3x | 8.61 | SEK 3 | 11.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Double Bond Pharma | Spotlight | Healthcare | Pharmaceuticals | SEK 31.49M | -2.3x | -0.08 | SEK 0.29 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
XP Chemistries AB | Stockholm | Healthcare | Pharmaceuticals | SEK 23.67M | -0.5x | -0.27 | SEK 0.12 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Lipigon Pharmaceuticals AB | Stockholm | Healthcare | Pharmaceuticals | SEK 22.25M | -0.9x | -0.2 | SEK 0.13 | -14% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
QuiaPEG Pharmaceutical | Stockholm | Healthcare | Pharmaceuticals | SEK 9.09M | -0.2x | -0 | SEK 0.005 | 22.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |